PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis
- Status
- UNKNOWN
- Phase
- NA
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Closed vs. Open Face Masks for Cranial Radiotherapy
- Status
- COMPLETED
- Phase
- NA
Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride
- Status
- UNKNOWN
- Phase
- PHASE4